Last reviewed · How we verify
NCT02333500
Oxytocin and Incitement to Use Olfactory Stimuli in Restrictive Anorexia Nervosa
NA trial testing olfactory workshop in Anorexia in 30 participants. Completed in 31 December 2018.
31 December 2018
Quick facts
| Lead sponsor | Fondation Lenval |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 30 |
| Start date | 11 February 2015 |
| Primary completion | 31 December 2018 |
| Estimated completion | 31 December 2018 |
| Sites | 1 location across France |
Drugs / interventions tested
- olfactory workshop
- other workshop
- No intervention
Conditions studied
- Anorexia — all drugs for Anorexia →
Sponsor
Fondation Lenval — full company profile →
Who can join
Adults 11 to 18, any sex, with Anorexia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective pilot study will compare adolescents with restrictive anorexia nervosa who participated for 3 months at olfactory workshops, patients who did not, and healthy patients.The groups will be evaluated before the workshops and after three months, with the wanting score after olfactory stimuli and with serum oxytocin level.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02333500
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anorexia
Currently open trials in the same condition.
- NCT06517199 — Olanzapine for Cancer Related Anorexia-cachexia Syndrome · Phase 3 · recruiting
- NCT04939090 — Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients · Phase 3 · active not recruiting
- NCT03637816 — Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer · Phase 2, PHASE3 · active not recruiting
- NCT00488072 — Effects of Mirtazapine on Appetite in Advanced Cancer Patients · Phase 2 · active not recruiting
Other Fondation Lenval trials
Trials by the same sponsor.
- NCT06968546 — Sufentanil Versus Ketamine Intranasally in the Management of Severe Acute Trauma-related Pain in Children. · Phase 2 · not yet recruiting
- NCT07383844 — Analysis of Barriers and Facilitators to Adapted Physical Activity for Pediatric Patients With Chronic Inflammatory Bowe · recruiting
- NCT07299006 — Evaluation of Paro, a Therapeutic Assistance Robot in Analgesic Management During the Placement of a Peripheral Intraven · NA · not yet recruiting
- NCT07068945 — Study of the Transition From Child Psychiatry to Adult Psychiatry in Nice Within a Population of 17-year-old Adolescents · not yet recruiting
- NCT06231654 — Evaluation of Remote Photoplethysmography to Assist Vital Signs Measure in Pediatrics · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02333500 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondation Lenval
- Last refreshed: 26 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02333500.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing